Merck & Company (MRK)

Merck & Co Inc. (MRK) Q4 2018 Results - Earnings Call Transcript
Feb. 1, 2019 | Price: Free! | Source: Seeking Alpha

Merck & Co., Inc. (MRK) at JPMorgan Healthcare Conference (Transcript)
Jan. 7, 2019 | Price: Free! | Source: Seeking Alpha

Merck & Co. (MRK) Q3 2018 Results - Earnings Call Transcript
Oct. 25, 2018 | Price: Free! | Source: Seeking Alpha

Merck & Co Inc. (MRK) Management Presents at Morgan Stanley Global Healthcare Conference 2018 - Bro
Sept. 12, 2018 | Price: Free! | Source: Seeking Alpha

Merck & Co Inc. (MRK) CEO Ken Frazier on Q2 2018 Results - Earnings Call Transcript
July 27, 2018 | Price: Free! | Source: Seeking Alpha

Merck & Co. (MRK) Q1 2018 Results - Earnings Call Transcript
May 1, 2018 | Price: Free! | Source: Seeking Alpha

Merck (MRK) Presents at Cowen and Company 35th Annual Health Care Conference (Transcript)
March 13, 2018 | Price: Free! | Source: Seeking Alpha

Merck's (MRK) CEO Ken Frazier on Q4 2017 Results - Earnings Call Transcript
Feb. 2, 2018 | Price: Free! | Source: Seeking Alpha

Merck's (MRK) Management Presents at 36th Annual JPMorgan Healthcare Conference (Transcript)
Jan. 9, 2018 | Price: Free! | Source: Seeking Alpha

Merck & Co. (MRK) Q3 2017 Results - Earnings Call Transcript
Oct. 27, 2017 | Price: Free! | Source: Seeking Alpha

Merck's (MRK) Management Presents at Morgan Stanley Healthcare Conference - Transcript
Sept. 11, 2017 | Price: Free! | Source: Seeking Alpha

Merck & Co. (MRK) Q2 2017 Results - Earnings Call Transcript
July 28, 2017 | Price: Free! | Source: Seeking Alpha

Merck's (MRK) Management Presents at Goldman Sachs Global Healthcare Conference (Transcript)
June 13, 2017 | Price: Free! | Source: Seeking Alpha

Merck's (MRK) Management Presents at Investor Briefing at 2017 ASCO Annual Meeting Conference (Tran
June 6, 2017 | Price: Free! | Source: Seeking Alpha

Merck's (MRK) CEO Ken Frazier Presents at Sanford Bernstein Strategic Decision Conference (Transcri
June 3, 2017 | Price: Free! | Source: Seeking Alpha

Merck & Co's (MRK) Annual Shareholders Meeting Brokers Conference (Transcript)
May 23, 2017 | Price: Free! | Source: Seeking Alpha

Merck & Co. (MRK) Q1 2017 Results - Earnings Call Transcript
May 2, 2017 | Price: Free! | Source: Seeking Alpha

Merck & Co. (MRK) Q4 2016 Results - Earnings Call Transcript
Feb. 2, 2017 | Price: Free! | Source: Seeking Alpha

Merck & Co. (MRK) Q3 2016 Results - Earnings Call Transcript
Oct. 25, 2016 | Price: Free! | Source: Seeking Alpha

Merck's (MRK) CEO Ken Frazier Presents at Morgan Stanley Global Healthcare Broker Conference (Trans
Sept. 12, 2016 | Price: Free! | Source: Seeking Alpha

Merck & Co's (MRK) Management Presents at Wells Fargo Healthcare Conference
Sept. 8, 2016 | Price: Free! | Source: Seeking Alpha

Merck & Co. (MRK) Kenneth C. Frazier on Q2 2016 Results - Earnings Call Transcript
July 29, 2016 | Price: Free! | Source: Seeking Alpha

Merck's (MRK) Management Presents at Oncology Event at ASCO 2016 (Transcript)
June 7, 2016 | Price: Free! | Source: Seeking Alpha

Merck & Co Inc. Investor Briefing At 2016 ASCO Meeting - Slides
June 6, 2016 | Price: Free! | Source: Seeking Alpha

Merck's (MRK) Management Presents at UBS Global Healthcare Brokers Conference (Transcript)
May 25, 2016 | Price: Free! | Source: Seeking Alpha

Merck & Co (MRK) Earnings Report: Q1 2016 Conference Call Transcript
May 5, 2016 | Price: Free! | Source: The Street

Merck & Co. (MRK) Kenneth C. Frazier on Q1 2016 Results - Earnings Call Transcript
May 5, 2016 | Price: Free! | Source: Seeking Alpha

Merk (MRK) Earnings Report: Q4 2015 Conference Call Transcript
Feb. 3, 2016 | Price: Free! | Source: The Street

Merck & Co (MRK) Q4 2015 Results - Earnings Call Webcast
Feb. 3, 2016 | Price: Free! | Source: Seeking Alpha

Merck's (MRK) CEO Ken Frazier on Q4 2015 Results - Earnings Call Transcript
Feb. 3, 2016 | Price: Free! | Source: Seeking Alpha

Merck & Co (MRK) Earnings Report: Q3 2015 Conference Call Transcript
Oct. 27, 2015 | Price: Free! | Source: The Street

Merck & Co (MRK) Q3 2015 Results - Earnings Call Webcast
Oct. 27, 2015 | Price: Free! | Source: Seeking Alpha

Merck & Co. (MRK) Kenneth C. Frazier on Q3 2015 Results - Earnings Call Transcript
Oct. 27, 2015 | Price: Free! | Source: Seeking Alpha

Merck & Co. Presents at Morgan Stanley Healthcare Brokers Conference (Transcript)
Sept. 17, 2015 | Price: Free! | Source: Seeking Alpha

Merck & Co. (MRK) Kenneth Frazier on Q2 2015 Results - Earnings Call Transcript
July 28, 2015 | Price: Free! | Source: Seeking Alpha

Merck (MRK) Earnings Report: Q2 2015 Conference Call Transcript
July 28, 2015 | Price: Free! | Source: The Street

Merck & Co (MRK) Q1 2015 Results - Earnings Call Webcast
April 28, 2015 | Price: Free! | Source: Seeking Alpha

Merck & Co. (MRK) Kenneth C. Frazier on Q1 2015 Results - Earnings Call Transcript
April 28, 2015 | Price: Free! | Source: Seeking Alpha

Merck (MRK) Earnings Report: Q1 2015 Conference Call Transcript
April 28, 2015 | Price: Free! | Source: The Street

Merck's (MRK) CEO Ken Frazier on Q4 2014 Results - Earnings Call Transcript
Feb. 4, 2015 | Price: Free! | Source: Seeking Alpha

Merck (MRK) Earnings Report: Q4 2014 Conference Call Transcript
Feb. 4, 2015 | Price: Free! | Source: The Street

Merck & Co (MRK) Q4 2014 Results - Earnings Call Webcast
Feb. 4, 2015 | Price: Free! | Source: Seeking Alpha

Merck's (MRK) CEO Ken Frazier on Q3 2014 Results - Earnings Call Transcript
Oct. 27, 2014 | Price: Free! | Source: Seeking Alpha

Merck & Co's CEO Ken Frazier Presents at Morgan Stanley Healthcare Conference -Transcript
Sept. 9, 2014 | Price: Free! | Source: Seeking Alpha

Merck's (MRK) CEO Lynn Fuller on Q2 2014 Results - Earnings Call Transcript
July 29, 2014 | Price: Free! | Source: Seeking Alpha

Q2 2014 Merck & Co Inc Earnings Conference Call (Webcast)
July 29, 2014 | Price: Free! | Source: Seeking Alpha

Merck's (MRK) Ken Frazier Hosts Annual Shareholder Meeting (Transcript)
May 28, 2014 | Price: Free! | Source: Seeking Alpha

Merck & Company, Inc. - Q1 2014 Earnings Call Transcript
April 29, 2014 | Price: $1.00 | Source: Earnings Impact

Merck & Co's CEO Discusses Q1 2014 Results - Earnings Call Transcript
April 29, 2014 | Price: Free! | Source: Seeking Alpha

Merck & Co Inc. Discusses Q1 2014 Results (Webcast)
April 29, 2014 | Price: Free! | Source: Seeking Alpha

Merck & Co Inc Q1 2014
April 29, 2014 | Price: Free! | Source: Morningstar

Merck & Co (MRK) Q3 2014 Results - Earnings Call Webcast
Feb. 27, 2014 | Price: Free! | Source: Seeking Alpha

Cubist Pharmaceuticals' (CBST) CEO Mike Bonney on Q3 2014 Results - Earnings Call Transcript
Feb. 21, 2014 | Price: Free! | Source: Seeking Alpha

Merck & Co Inc Q4 2013
Feb. 5, 2014 | Price: Free! | Source: Morningstar

Merck & Company, Inc. - Q4 2013 Earnings Call Transcript
Feb. 5, 2014 | Price: Free! | Source: Earnings Impact

Merck & Co. Inc.'s CEO Discusses Q4 2013 Results - Earnings Call Transcript
Feb. 5, 2014 | Price: Free! | Source: Seeking Alpha

Q4 2013 Merck & Co Inc Earnings Conference call (Webcast)
Feb. 5, 2014 | Price: Free! | Source: Seeking Alpha

Merck & Co., Inc. at Credit Suisse Healthcare Conference Transcript
Nov. 12, 2013 | Price: $106.00 | Source: Thomson

Merck & Co Inc Q3 2013
Oct. 28, 2013 | Price: Free! | Source: Morningstar

Merck & Co Inc. Discusses Q3 2013 Results (Webcast)
Oct. 28, 2013 | Price: Free! | Source: Seeking Alpha

Merck & Company, Inc. - Q3 2013 Earnings Call Transcript
Oct. 28, 2013 | Price: Free! | Source: Earnings Impact

Merck & Co., Inc. Q3 2013 Earnings Conference Call Transcript
Oct. 28, 2013 | Price: $106.00 | Source: Thomson

Merck & Co. Inc.'s CEO Discusses Q3 2013 Results - Earnings Call Transcript
Oct. 28, 2013 | Price: Free! | Source: Seeking Alpha

Merck & Company, Inc. - Global Initiative to Sharpen Commercial and R&D Focus Transcript
Oct. 1, 2013 | Price: Free! | Source: Earnings Impact

Merck Announces Global Initiative to Sharpen Commercial and R&D Focus Transcript
Oct. 1, 2013 | Price: $54.00 | Source: Thomson

Merck & Co., Inc. at Morgan Stanley Healthcare Conference Transcript
Sept. 11, 2013 | Price: $106.00 | Source: Thomson

Merck & Co. Inc. (MRK) Management Discusses Q2 2013 Results (Webcast)
July 30, 2013 | Price: Free! | Source: Seeking Alpha

Merck & Co Inc Q2 2013
July 30, 2013 | Price: Free! | Source: Morningstar

Merck & Co., Inc. Q2 2013 Earnings Conference Call Transcript
July 30, 2013 | Price: $106.00 | Source: Thomson

Merck's CEO Discusses Q2 2013 Results - Earnings Call Transcript
July 30, 2013 | Price: Free! | Source: Seeking Alpha

Merck & Company, Inc. - Q2 2013 Earnings Call Transcript
July 30, 2013 | Price: Free! | Source: Earnings Impact

Merck & Co., Inc. at Sanford C Bernstein Strategic Decisions Conference Transcript
May 31, 2013 | Price: $106.00 | Source: Thomson

Merck's Management Presents at Sanford C. Bernstein Twenty-Ninth Annual Strategic Decisions Confere
May 31, 2013 | Price: Free! | Source: Seeking Alpha

Merck & Co Inc. CEO Hosts Annual Shareholder Meeting (Transcript)
May 28, 2013 | Price: Free! | Source: Seeking Alpha

Merck & Co., Inc. Management Presents at UBS Global Healthcare Conference (Transcript)
May 20, 2013 | Price: Free! | Source: Seeking Alpha

Merck & Co., Inc. at UBS Global Healthcare Conference Transcript
May 20, 2013 | Price: $106.00 | Source: Thomson

Merck & Co., Inc. at Bank of America Merrill Lynch Health Care Conference Transcript
May 15, 2013 | Price: $106.00 | Source: Thomson

Merck & Co Inc Q1 2013
May 1, 2013 | Price: Free! | Source: Morningstar

Merck & Co., Inc. Q1 2013 Earnings Conference Call Transcript
May 1, 2013 | Price: $106.00 | Source: Thomson

Merck's CEO Discusses Q1 2013 Results - Earnings Call Transcript
May 1, 2013 | Price: Free! | Source: Seeking Alpha

Merck & Co., Inc. at Cowen Health Care Conference Transcript
March 6, 2013 | Price: $54.00 | Source: Thomson

Merck & Co., Inc. at Citi Global Healthcare Conference Transcript
Feb. 27, 2013 | Price: $106.00 | Source: Thomson

Merck & Co., Inc. at Leerink Swann Global Healthcare Conference Transcript
Feb. 13, 2013 | Price: $106.00 | Source: Thomson

Merck & Co Inc Q4 2012
Feb. 1, 2013 | Price: Free! | Source: Morningstar

Merck CEO Discusses Q4 2012 Results - Earnings Call Transcript
Feb. 1, 2013 | Price: Free! | Source: Seeking Alpha

Merck & Co., Inc. at JPMorgan Global Healthcare Conference Transcript
Jan. 8, 2013 | Price: $106.00 | Source: Thomson

Merck & Co., Inc. at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top Conference Trans
Jan. 3, 2013 | Price: $106.00 | Source: Thomson

Merck & Co., Inc. Q3 2012 Earnings Conference Call Transcript
Oct. 26, 2012 | Price: $106.00 | Source: Thomson

Merck & Co. Management Discusses Q3 2012 Results - Earnings Call Transcript
Oct. 26, 2012 | Price: Free! | Source: Seeking Alpha

Merck & Co Inc Q3 2012
Oct. 26, 2012 | Price: Free! | Source: Morningstar

Merck & Co., Inc. at UBS Global Life Sciences Conference Transcript
Sept. 20, 2012 | Price: $54.00 | Source: Thomson

Merck & Co., Inc. at Morgan Stanley Healthcare Conference Transcript
Sept. 11, 2012 | Price: $54.00 | Source: Thomson

Merck & Co Inc(MRK) Q2 2012 Earnings Call Transcript
July 27, 2012 | Price: Free! | Source: Morningstar

Merck & Co. Management Discusses Q2 2012 Results - Earnings Call Transcript
July 27, 2012 | Price: Free! | Source: Seeking Alpha

Merck & Co., Inc. Q2 2012 Earnings Conference Call Transcript
July 27, 2012 | Price: $54.00 | Source: Thomson

Merck's Management Host Conference on Suvorexant Phase III Data (Transcript)
June 13, 2012 | Price: Free! | Source: Seeking Alpha

Merck & Co.'s CEO Discusses Q1 2012 Results - Earnings Call Transcript
April 27, 2012 | Price: Free! | Source: Seeking Alpha

Merck & Co Inc(MRK) Q1 2012 Earnings Call Transcript
April 27, 2012 | Price: Free! | Source: Morningstar

Merck & Co Inc(MRK) Q4 2011 Earnings Call Transcript
Feb. 2, 2012 | Price: Free! | Source: Morningstar

Merck & Co.'s CEO Discusses Q4 2011 Results - Earnings Call Transcript
Feb. 2, 2012 | Price: Free! | Source: Seeking Alpha

Merck & Co. Inc. - Special Call
Nov. 10, 2011 | Price: Free! | Source: Seeking Alpha

Merck & Co Inc(MRK) Q3 2011 Earnings Call Transcript
Oct. 28, 2011 | Price: Free! | Source: Morningstar

Merck & Co.'s CEO Discusses Q3 2011 Results - Earnings Call Transcript
Oct. 28, 2011 | Price: Free! | Source: Seeking Alpha

Merck & Co Inc(MRK) Q2 2011 Earnings Call Transcript
July 29, 2011 | Price: Free! | Source: Morningstar

Merck & Co.'s CEO Discusses Q2 2011 Results - Earnings Call Transcript
July 29, 2011 | Price: Free! | Source: Seeking Alpha

Merck & Co Inc(MRK) Q1 2011 Earnings Call Transcript
April 29, 2011 | Price: Free! | Source: Morningstar

Merck & Co.'s CEO Discusses Q1 2011 Results - Earnings Call Transcript
April 29, 2011 | Price: Free! | Source: Seeking Alpha

Merck & Co.'s CEO Discusses Q4 2010 Results - Earnings Call Transcript
Feb. 3, 2011 | Price: Free! | Source: Seeking Alpha

Merck & Co Inc(MRK) Q4 2010 Earnings Call Transcript
Feb. 3, 2011 | Price: Free! | Source: Morningstar

Merck & Co Inc(MRK) Q3 2010 Earnings Call Transcript
Oct. 29, 2010 | Price: Free! | Source: Morningstar

Merck CEO Discusses Q3 2010 Results - Earnings Call Transcript
Oct. 29, 2010 | Price: Free! | Source: Seeking Alpha

Merck & Co Inc(MRK) Q2 2010 Earnings Call Transcript
July 30, 2010 | Price: Free! | Source: Morningstar

Merck & Co. Q2 2010 Earnings Call Transcript
July 30, 2010 | Price: Free! | Source: Seeking Alpha

Merck & Co Inc(MRK) Q1 2010 Earnings Call Transcript
May 4, 2010 | Price: Free! | Source: Morningstar

Merck & Co. Q1 2010 Earnings Call Transcript
May 4, 2010 | Price: Free! | Source: Seeking Alpha

Merck & Co., Inc. Q4 2009 Earnings Call Transcript
Feb. 16, 2010 | Price: Free! | Source: Seeking Alpha

Merck & Co., Inc. Q3 2009 Earnings Call Transcript
Oct. 22, 2009 | Price: Free! | Source: Seeking Alpha

Merck & Co. Inc. Q2 2009 Earnings Call Transcript
July 21, 2009 | Price: Free! | Source: Seeking Alpha

Merck F1Q09 Earnings Call Transcript
April 21, 2009 | Price: Free! | Source: Seeking Alpha

Merck & Co. Q4 2008 Earnings Call Transcript
Feb. 3, 2009 | Price: Free! | Source: Seeking Alpha

Merck & Co., Inc. Guidance Call Transcript
Dec. 4, 2008 | Price: Free! | Source: Seeking Alpha

Merck & Co. Inc. Q3 2008 Earnings Conference Call Transcript
Oct. 22, 2008 | Price: Free! | Source: Seeking Alpha

Merck & Co., Inc. Q2 2008 Earnings Call Transcript
July 21, 2008 | Price: Free! | Source: Seeking Alpha

Merck & Co., Inc. Q1 2008 Earnings Call Transcript
April 21, 2008 | Price: Free! | Source: Seeking Alpha

Merck & Co., Inc. Q4 2007 Earnings Call Transcript
Jan. 30, 2008 | Price: Free! | Source: Seeking Alpha

Merck Financial Guidance Call Transcript
Dec. 4, 2007 | Price: Free! | Source: Seeking Alpha

Merck Q3 2007 Earnings Call Transcript
Oct. 22, 2007 | Price: Free! | Source: Seeking Alpha

Merck & Co. Q2 2007 Earnings Call Transcript
July 23, 2007 | Price: Free! | Source: Seeking Alpha

Merck Q1 2007 Earnings Call Transcript
April 19, 2007 | Price: Free! | Source: Seeking Alpha

Merck Q4 2006 Earnings Call Transcript
Jan. 30, 2007 | Price: Free! | Source: Seeking Alpha

Merck Q3 2006 Earnings Call Transcript
Oct. 20, 2006 | Price: Free! | Source: Seeking Alpha

Recent filings

Major owner of Merck & Company just picked up 12,955,016 shares - April 9, 2019

Merck Sharp & Dohme Corp. just provided an update on share ownership of Merck & Company - April 9, 2019

Merck &: Confidential, For Use Of The Commission Only (As Permitted By Rule 14A-6(E)(2)) Definitive Proxy Statement Definitive Additional Materials - April 8, 2019

Other definitive proxy statements - April 8, 2019

Merck &: Confidential, For Use Of The Commission Only (As Permitted By Rule 14A-6(E)(2)) Definitive Proxy Statement Definitive Additional Materials - April 8, 2019

Major owner of Merck & Company just declared 0 ownership of the company. - April 3, 2019

Merck & Company director just declared owning 5,100 shares of Merck & Company - April 2, 2019

Merck & Company director just declared owning 100 shares of Merck & Company - April 2, 2019

Merck & Company director just declared owning 100 shares of Merck & Company - April 2, 2019

Merck & Company director just declared owning 1,000 shares of Merck & Company - April 2, 2019

Merck & Company director just declared owning 10 shares of Merck & Company - April 2, 2019

Merck & Company director just declared owning 6,351 shares of Merck & Company - April 2, 2019

Merck & Company director just declared owning 100 shares of Merck & Company - April 2, 2019

Tender offer statement by Third Party - April 2, 2019

Merck & Company's SVP Chief Ethics & Com Officer just declared owning 1,345 shares of Merck & Company - March 28, 2019

EVP of Merck & Company just cashed-in 192,572 options - March 27, 2019

Tender offer statement by Third Party - March 26, 2019

Merck & Company director just declared owning 10 shares of Merck & Company - March 20, 2019

Chairman of Merck & Company just cashed-in 192,736 options - March 20, 2019

Merck & Company director just declared owning 10 shares of Merck & Company - March 20, 2019

Tender offer statement by Third Party - March 15, 2019

Chairman of Merck & Company just cashed-in 18,725 options - March 14, 2019

The Notes are being issued under an indenture dated as of - March 7, 2019

Chairman of Merck & Company just cashed-in 20,105 options - March 6, 2019

Filing under Securities Act Rules 163/433 of free writing prospectuses - March 6, 2019

Merck & Company just filed a prospectus, suggesting it plans to soon issue some securities - March 6, 2019

Tender offer statement by Third Party - March 5, 2019

Merck & Company just filed a prospectus, suggesting it plans to soon issue some securities - March 5, 2019

Exe V-P & Pres of Merck & Company just picked up 32,937 shares - Feb. 27, 2019

Merck & Company's Exe V-P & Pres. MMD just picked up 10,380 shares - Feb. 27, 2019

Chairman of Merck & Company just picked up 105,765 shares - Feb. 27, 2019

Merck & Company's Sr. VP Fince-Global Controller just picked up 2,330 shares - Feb. 27, 2019

EVP Strat Comm of Merck & Company just picked up 8,747 shares - Feb. 27, 2019

EVP of Merck & Company just picked up 4,017 shares - Feb. 27, 2019

EVP of Merck & Company just picked up 1,527 shares - Feb. 27, 2019

EVP of Merck & Company just picked up 30,610 shares - Feb. 27, 2019

EVP&Pres of Merck & Company just picked up 13,507 shares - Feb. 27, 2019

Merck & Company Just Filed Its Annual Report: Earnings per ShareTh... - Feb. 27, 2019

Chairman of Merck & Company just cashed-in 95,953 options - Feb. 22, 2019

Written communication relating to an issuer or third party - Feb. 21, 2019

Chairman of Merck & Company just cashed-in 135,613 options - Feb. 19, 2019

Merck & Company director just cashed-in 5,000 options - Feb. 14, 2019

Merck & Company's Exe V-P & Pres. MMD just cashed-in 73,727 options - Feb. 14, 2019

Merck Sharp & Dohme Corp. just issued a filing suggesting it has sold all of its Merck & Company - Feb. 14, 2019

Merck & Company's Sr. VP Fince-Global Controller just cashed-in 64,662 options - Feb. 14, 2019

MRL Ventures Fund LLC just provided an update on share ownership of Merck & Company - Feb. 14, 2019

The Vanguard Group just provided an update on share ownership of Merck & Company - Feb. 11, 2019

Merck & Company director just picked up 1,948 shares - Feb. 11, 2019

Chairman of Merck & Company just cashed-in 231,566 options - Feb. 6, 2019

BlackRock, Inc. just provided an update on share ownership of Merck & Company - Feb. 6, 2019

Merck & Company director just cashed-in 10,000 options - Feb. 4, 2019

Merck & Co., Inc CONSOLIDATED STATEMENT OF INCOME - GAAP (AMOUNTS IN MILLIONS, EXCEPT PER SHARE FIGURES) (UNAUDITED) - Feb. 1, 2019

Merck &: Merck Announces Fourth-Quarter And Full-Year 2018 Financial Results - Feb. 1, 2019

Merck &: Mary Ellen Coe Elected To Merck Board Of Directors - Jan. 30, 2019

EVP of Merck & Company just declared owning 63,119 shares of Merck & Company - Jan. 10, 2019

EVP of Merck & Company just declared owning 1,365 shares of Merck & Company - Jan. 10, 2019

Merck & Company director just declared owning 5,100 shares of Merck & Company - Jan. 3, 2019

Merck & Company director just declared owning 100 shares of Merck & Company - Jan. 3, 2019

Merck & Company director just declared owning 1,000 shares of Merck & Company - Jan. 3, 2019

Merck & Company director just declared owning 100 shares of Merck & Company - Jan. 3, 2019

Merck & Company director just declared owning 100 shares of Merck & Company - Jan. 3, 2019

Merck & Company director just declared owning 6,351 shares of Merck & Company - Jan. 3, 2019

Departure of Directors or Certain - Dec. 10, 2018

EVP Strat Comm of Merck & Company just cashed-in 36,218 options - Nov. 8, 2018

Merck & Company Just Filed Its Quarterly Report: Earnings Per ShareTh... - Nov. 6, 2018

Merck & Company's EVP & Pres-Global Human Health just cashed-in 277,879 options - Nov. 2, 2018

Merck & Company's SVP Chief Ethics & Com Officer just cashed-in 47,036 options - Nov. 1, 2018

EVP&Pres of Merck & Company just cashed-in 25,467 options - Nov. 1, 2018

Merck &: Merck Announces Third-Quarter 2018 Financial Results - Oct. 25, 2018

EVP of Merck & Company just declared 0 ownership of the company. - Oct. 5, 2018

Departure of Directors or Certain - Oct. 4, 2018

Merck Sharp & Dohme Corp. just provided an update on share ownership of Merck & Company - Oct. 4, 2018

Major owner of Merck & Company just picked up 2,723,509 shares - Oct. 2, 2018

Merck &: Merck Board Rescinds Mandatory Ceo Retirement Policy - Sept. 27, 2018

Major owner of Merck & Company just declared 0 ownership of the company. - Sept. 26, 2018

Chairman of Merck & Company just cashed-in 279,851 options - Sept. 19, 2018

Merck & Company's EVP & Pres-Global Human Health just disposed of 7,360 shares - Sept. 18, 2018

Merck & Company's Exe V-P & Pres. MMD just cashed-in 29,208 options - Aug. 6, 2018

Merck & Company's Sr. VP Fince-Global Controller just disposed of 5,000 shares - Aug. 2, 2018

Chairman of Merck & Company just disposed of 18,747 shares - Aug. 1, 2018

Merck &: Merck Announces Second-Quarter 2018 Financial Results - July 27, 2018

Merck & Company director just declared owning 5,100 shares of Merck & Company - July 2, 2018

Merck & Company director just declared owning 6,351 shares of Merck & Company - July 2, 2018

Merck & Company director just declared owning 100 shares of Merck & Company - July 2, 2018

Merck & Company director just declared owning 100 shares of Merck & Company - July 2, 2018

Merck & Company director just declared owning 100 shares of Merck & Company - July 2, 2018

Merck & Company director just declared owning 1,000 shares of Merck & Company - July 2, 2018

Annual report of employee stock purchase, savings and similar plans - June 19, 2018

Annual report of employee stock purchase, savings and similar plans - June 19, 2018

Merck & Company's EVP & Pres-Global Human Health just disposed of 34,094 shares - June 19, 2018

Annual report of employee stock purchase, savings and similar plans - June 19, 2018

Merck & Company director just declared owning 100 shares of Merck & Company - May 29, 2018

Merck & Company director just declared owning 100 shares of Merck & Company - May 29, 2018

Merck & Company director just declared owning 100 shares of Merck & Company - May 29, 2018

Merck & Company director just declared owning 3,352 shares of Merck & Company - May 29, 2018

Merck & Company director just declared owning 13,148 shares of Merck & Company - May 29, 2018

Merck & Company director just declared owning 100 shares of Merck & Company - May 29, 2018

Merck & Company director just declared owning 6,351 shares of Merck & Company - May 29, 2018

Merck & Company director was just granted 3,131 restricted shares - May 29, 2018

Merck & Company director just declared owning 1,000 shares of Merck & Company - May 29, 2018

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. VANGUARD GROUP INC 202,833,998 0.5 Sept. 30, 2018
2. Wellington Management Company LLP 130,248,283 N/A Feb. 10, 2016
3. State Street Corp 111,673,630 0.7 Dec. 31, 2018
4. WELLINGTON MANAGEMENT CO LLP 94,105,312 0.2 Dec. 31, 2017
5. Capital World Investors 91,790,796 1.9 Dec. 31, 2018
6. WELLINGTON MANAGEMENT CO LLP 76,042,840 N/A March 31, 2018
7. BlackRock Institutional Trust Company, N.A. 75,624,644 0.6 Dec. 31, 2016
8. BlackRock Fund Advisors 45,572,909 0.4 Sept. 30, 2016
9. BANK OF AMERICA CORP /DE/ 45,002,692 0.1 Sept. 30, 2017
10. PRICE T ROWE ASSOCIATES INC /MD/ 40,785,831 0.5 Dec. 31, 2018
11. FRANKLIN RESOURCES INC 40,307,942 0.3 Sept. 30, 2018
12. GEODE CAPITAL MANAGEMENT, LLC 34,032,366 0.5 Dec. 31, 2018
13. JPMORGAN CHASE & CO 33,324,862 0.1 Sept. 30, 2017
14. NORTHERN TRUST CORP 33,318,753 0.1 March 31, 2018
15. Capital International Investors 33,217,417 1.2 Dec. 31, 2018
16. FRANKLIN RESOURCES INC 29,049,968 N/A Dec. 31, 2018
17. NORGES BANK 28,356,086 0.8 Dec. 31, 2018
18. GOLDMAN SACHS GROUP INC 26,716,293 0.2 Dec. 31, 2018
19. BlackRock Group LTD 26,150,252 0.1 Sept. 30, 2016
20. DEUTSCHE BANK AG\ 23,735,898 0.1 Dec. 31, 2017
21. WELLS FARGO & COMPANY/MN 23,611,585 N/A Sept. 30, 2018
22. Ameriprise Financial Inc 22,050,680 0.2 Dec. 31, 2017
23. DEUTSCHE BANK AG\ 21,326,492 N/A June 30, 2018
24. HENDERSON GROUP PLC 21,301,987 1.0 Dec. 31, 2018
25. Invesco Ltd. 20,531,555 N/A June 30, 2018
26. Invesco Ltd. 17,519,210 N/A Dec. 31, 2017
27. BlackRock Advisors LLC 16,161,113 0.5 Sept. 30, 2016
28. JENNISON ASSOCIATES LLC 15,777,286 0.7 Dec. 31, 2018
29. MORGAN STANLEY 15,590,924 N/A Dec. 31, 2016
30. STATE FARM MUTUAL AUTOMOBILE INSURANCE CO 15,145,800 0.9 Dec. 31, 2018

Merck & Company (MRK)

140
 


Feedback